Stasa Stankovic

OvartiX

Co-Founder

Cambridge University Genomic Medicine PhD on a mission to reshape the future of women’s health by developing prediction tools and next generation therapeutics for female reproductive disorders.

A young leader with an excellent international academic record (Nature, Science, Nature Medicine) and outstanding achievements in health-tech transfer and innovations. Based on her impact, Stasa was awarded ‘McKinsey&Company Next Generation Women Leader’ for 2020, the best young investigator under the age of 40 by the International Menopause Society (‘Robert Greenblatt Award’), one of ten best UK young scientists in the biomedical sector by the UK Government ‘STEM for Britain’, and she is considered as one of 11 scientists with the highest impact on innovations in women’s health and menopause by Forbes.

Life Science Integrates
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.